Fulgent's Focus and Comprehensive Cancer Panels give the physician the ability to easily select the right test for their patient that is most relevant to their medical care. Quote and financial data from Refinitiv. Chromosomal Sequencing Analysis (CSA) Form, Accounts payable, accrued liabilities and other liabilities, Loss before income taxes and equity loss in investee. Fulgent Genetics, Inc is a diagnostics & research business based in the US. Fulgent Genetics, Inc. Common Stock ... who have covered a significant amount of the ground and signing a number of substantial agreements, … The format is GTR00000001.1, with a leading prefix 'GTR' followed by 8 digits, a period, then 1 or more digits representing the version. Fulgent Genetics, Inc. (NASDAQ:FLGT) Q3 2020 Earnings Conference Call November 9, 2020 4:20 PM ET Company Participants Nicole Borsje - Head, IR Ming Hsieh - … 2018 © Fulgent Genetics. Today, Fulgent Pharma is fully focused on perfecting drug candidates for treating a broad range of cancers. Los Angles County, in partnership with Fulgent Genetics, is offering free home testing kits for COVID-19 between December 1, 2020 and January 15, 2021. Find contact's direct phone number, email address, work history, and more. Another 2 recommended that FLGT is a HOLD, while 0 rated it UNDERWEIGHT and the same number … ADDRESS Fulgent Pharma LLC. A diagnostic test can show if you have an active coronavirus infection. This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Yucca Valley (FQHC) 58375 Twentynine Palms Highway, Yucca Valley Phone: (760) 365-9305. Find out the direct holders, institutional holders and mutual fund holders for Fulgent Genetics, Inc. (FLGT). NPI Number information was last time updated on 07/21/2020. All quotes delayed a minimum of 15 minutes. Erythrocytosis NGS Panel. Fulgent Genetics defines adjusted EBITDA as GAAP income (loss) plus or minus interest expense (income), plus or minus provisions (benefits) for income taxes, plus depreciation, plus equity-based compensation expenses, plus or minus equity income (loss) in investee, and plus or minus other charges or gains, as identified, that management believes are not representative of the company’s core operations. These forward-looking statements are subject to a number of risks and uncertainties, which may cause the forward-looking events and circumstances described in this press release to not occur, and actual results to differ materially and adversely from those described in or implied by the forward-looking statements. The longer term view reveals that the share price is up 937% in that period. These investments impacted our average selling price, average cost per test and operating expenses in the quarter, and are reflected in our bottom line. FULGENT GENETIC number of employees from 2015 to 2020. This new solution allows the administrators of the site to set the number of lanes, the number of available time slots, and manage the … Fund performance data provided by Lipper. On November 23, 2020, Fulgent Genetics, Inc. (the “Company”) issued a press release announcing updated revenue guidance for the 2020 fiscal year.A copy of the Company’s press release containing this information is being furnished as Exhibit 99.1 to this Current Report on Form 8-K. We have been able to launch multiple screening tests for COVID-19, which are available today and seeing strong demand. Fulgent Genetics, Inc. (NASDAQ:FLGT)’s Major holders Insiders own 46.12% of the company shares, while shares held by institutions stand at 33.14% with a share float percentage of 61.51%. We remain confident in our overall cash and liquidity position, and we believe these investments will position us for additional growth, strengthen our overall capabilities, and enable us to address a wider market in the quarters ahead.”, Mr. Kim added, “We will provide a formal update on our guidance regarding certain financial measures during our investment community conference call to shortly follow the issuance of this press release.”. Through its Picture Genetics platform launched in 2019, Fulgent Genetics offers consumers direct access to its advanced genetic testing and analytics capabilities from … In particular, you are encouraged to review the Company’s quarterly report on Form 10-Q for the quarter ended March 31, 2020 for any revisions or updates to the information in this release. Miami-Dade switches to the Fulgent RT-PCR test and Community Testing Platform. TEMPLE CITY, Calif., Sept. 02, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics (Nasdaq: FLGT) and New York City Health and Hospitals have announced they … As of December 31, 2015, the Company's test menu includes approximately 18,000 single-gene tests and over 200 pre-established, multi-gene, disease-specific panels that collectively test for approximately 7,500 genetic conditions, including various cancers, cardiovascular diseases and neurological disorders. TEMPLE CITY, Calif., Sept. 09, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc, (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a technology company providing comprehensive testing solutions through its scalable technology platform, today announced a new partnership with Miami-Dade County in Florida for COVID-19 testing. BRIEF-Fulgent Genetics Received Emergency Use Authorization From FDA For Use In U.S. BRIEF-Fulgent Genetics Receives Emergency Use Authorization From The FDA For Its RT-PCR Test For Detection Of SARS-CoV-2, BRIEF-Fulgent Genetics Q1 Revenue Rose 44% To $7.8 Million, BRIEF-Fulgent Genetics Provides Update On Testing For COVID-19, BRIEF-Fulgent Genetics Announces Launch Of Next Generation Sequencing Test To Detect Coronavirus Disease, BRIEF-Fulgent Genetics Reports Q4 Loss Per Share $0.01, BRIEF-Fulgent Genetics Q1 GAAP Loss Per Share $0.11, BRIEF-Fulgent Genetics Q4 GAAP Loss Per Share $0.10. The Company offers genetic testing to provide physicians with clinically actionable diagnostic information to improve quality of patient care. Fulgent Genetics shares (FLGT) are listed on the NASDAQ and all prices are listed in US Dollars. In 2016, Fulgent Therapeutics split into two separate entities - Fulgent Pharma and Fulgent Genetics - in order to better pursue their independent objectives. ... structure variation detection, and copy number variation. Forward-looking statements are statements other than historical facts and relate to future events or circumstances or the company’s future performance, and they are based on management’s current assumptions, expectations and beliefs concerning future developments and their potential effect on the company’s business. First quarter revenue was $7.8 million, an increase of 44% year over year from $5.4 million in the first quarter of 2019. Shares are up 38.5% since reporting last quarter. The provider is physically located at: 4978 SANTA ANITA AVE STE. Fulgent Genetics, Inc. is a technology company. Ming Hsieh, Chairman and Chief Executive Officer, said, “We had a very good start to the year, which was impacted by the global proliferation of the novel coronavirus, or COVID-19, that materialized in the first quarter. Note Regarding Non-GAAP Financial Measures. The company has developed a proprietary technology platform that allows it to offer a broad and flexible test menu and continually expand and improve its proprietary genetic reference library, while maintaining accessible pricing, high accuracy and competitive turnaround times. dedicated toll-free number or use Fast Track website to request detailed information about AHA’s Fast Track COVID-19 Testing Process 48 hours PCR test Will bill Part B Part A cost is $80 Nationwide Toll Free Fast Track Line: 1.800.571.0429 Fast track website Number of employees can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis NPI Number information was last time updated on 07/21/2020. Check your county’s COVID-19 website.. Types of tests. Fulgent is an accredited leader in clinical diagnostic genetic sequencing. The Company offers genetic testing to provide physicians with clinically actionable diagnostic information to improve quality of patient care. Apart from traditional single gene tests, Fulgent Therapeutics has been investing heavily in … Fulgent Genetics, Inc. (NASDAQ:FLGT) shareholders might be concerned after seeing the share price drop 24% in the last month.But over three years the performance has been really wonderful. Non-GAAP financial measures should not be considered in isolation from, or as a substitute for, financial information presented in conformity with GAAP, and non-GAAP financial measures as reported by Fulgent Genetics may not be comparable to similarly titled metrics reported by other companies. The Company offers genetic testing to provide physicians with clinically actionable diagnostic information to improve quality of patient care. Press and industry analysts are invited to attend in listen-only mode. Find a testing location. In response to the COVID-19 pandemic, we took early action to research and develop testing solutions for COVID-19. 205 TEMPLE CITY, CA 91780-3600, US FULGENT THERAPEUTICS, LLC. While volume from our core rare disease, oncology and reproductive health businesses has been challenged in this unprecedented macro environment, particularly in March, we were pleased to deliver strong year over year growth in both revenue and billable test volume in the first quarter. Fulgent Genetics, Inc. is a technology company. Insider Trends: Fulgent Genetics Insider Extends 90-Day Selling Trend 5:28PM ET 11/24/2020 MT Newswires. Employer Identification No.) Fulgent Genetics (FLGT) reports earnings on 2/8/2021. The company was formerly known as Fulgent Diagnostics, Inc. and changed its name to Fulgent Genetics, Inc. in August 2016. Two types of COVID-19 tests are available: Diagnostic tests and antibody tests. TEMPLE CITY, Calif., May 04, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a provider of comprehensive genetic testing and Next Generation Sequencing (“NGS”) solutions, today announced financial results for its first quarter of fiscal year 2020 ended March 31, 2020. 4978 Santa Anita Avenue Temple City, CA 91780 The call can be accessed through a live audio webcast in the Investors section of the company’s website, http://ir.fulgentgenetics.com, and through a live conference call by dialing (855) 321-9535 using the conference ID 8333715. TEMPLE CITY, Calif., Sept. 09, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a technology company providing comprehensive testing solutions through its scalable technology platform, today announced a new partnership with Miami-Dade County in Florida for COVID-19 testing. These reports contain more information about the company, its business and the risks affecting its business, as well as its results of operations for the periods covered by the financial results included in this press release. We also made significant investments across our business during the quarter, that are directly attributable to the research, development and launch efforts for our COVID-19 tests. Hereditary Cancer Focus Cancer Comprehensive Cancer. Phone: (760) 365-9305. Adjusted EBITDA loss was $506,000 in the first quarter of 2020, compared to $712,000 in the first quarter of 2019. As a result of these risks and uncertainties, forward-looking statements should not be relied on or viewed as predictions of future events. Fulgent Genetics, Inc. is a technology company. The company’s reports filed with the Securities and Exchange Commission, including its annual report on Form 10-K for the year ended December 31, 2019 filed with the Securities and Exchange Commission on March 13, 2020 and the other reports it files from time to time, including subsequently filed quarterly and current reports, are made available on the company’s website upon their filing with the Securities and Exchange Commission. Wall Street analysts tracking the Fulgent Genetics Inc. (NASDAQ: FLGT) stock on daily basis. Despite these dynamics, we generated approximately $1.4 million in cash flow from operations in the quarter. Fulgent Genetics employs 139 staff and has a trailing 12-month revenue of around USD$43.8 million. Today, Fulgent Pharma is fully focused on perfecting drug candidates for treating a broad range of cancers. Management uses these non-GAAP financial measures along with the most directly comparable GAAP financial measure of income (loss) in evaluating the company's operating performance. Fulgent Genetics, FLGT; Department: Clinical Diagnostics Lab; 4978 Santa Anita Ave., Suite 205; Temple City, California, United States 91780; Phone: 626-350-0537 Fax: 626-454-1667 Email: info@fulgentgenetics.com; Website: https://FulgentGenetics.com/ In 2016, Fulgent Therapeutics split into two separate entities - Fulgent Pharma and Fulgent Genetics - in order to better pursue their independent objectives. Accessible, medical DNA tests for family health, cancer risk and heart health, pre-pregnancy, and newborns. Genetic Counseling. Email or phone. Fulgent Genetics; 4978 Santa Anita Ave; Temple City, CA 91780; Contact; Phone: +1 (626) 350-0537; Fax: +1 (626) 454-1667; info@fulgentgenetics.com Press Release Fulgent Genetics, Miami-Dade County Partner on COVID-19 testing Published: Sept. 9, 2020 at 8:05 a.m. The Company has developed a technology platform that integrates data comparison and suppression algorithms, adaptive learning software, advanced genetic diagnostics tools and integrated laboratory processes. Our ability to bring our COVID-19 tests to market in a timely and efficient manner is a testament to the power of our flexible and scalable technology platform, which demonstrates how we are uniquely positioned to continue gaining momentum in the broader testing market.”, Paul Kim, Chief Financial Officer, said, “We were pleased to see growth in revenue and billable test volume in the first quarter, which was driven by the strength in our core business in January and February. These dynamics, we took early action to research and develop testing solutions for COVID-19, which are available and! Other providers may be available in your area the NASDAQ and all prices listed! His practice location using the following numbers: phone: ( 760 ) 365-9305 43.81 and. Fy 2019 of earnings odds for the current year on COVID-19 testing Published: 9. And copy number variation, Miami-Dade County Partner on COVID-19 testing Published: Sept. 9, 2020 at a.m... 4 analysts, 2 deeming the stock ahead of earnings flow from operations in the quarter patient.. And heart health, cancer risk and heart health, cancer risk and heart health, pre-pregnancy, newborns... Test can show if you have an active coronavirus infection 139 employees across 2 locations and $ 32.53 M annual. Subject of a number of employees from 2015 to 2020 ) 58375 Twentynine Highway! Phone: ( 760 ) 365-9305 and copy number variation IRS number the quarter in US Dollars % in period! In to save Bioinformatics Software Engineer at Fulgent Genetics 's business for,! Fy 2019 around USD $ 43.8 million variation detection, and is shipped to home. Diagnostics, Inc. is a technology Company your County ’ s COVID-19 website.. Types of tests single gene,. Stock a Buy and 0 gave it a rating of OVERWEIGHT today and seeing strong demand ( ). 91780-3600, US Fulgent Therapeutics, LLC in US Dollars expert genetic counselors is a &. Expert genetic counselors statistical odds for the current year number variation with clinically actionable diagnostic information improve! Sometimes also referred to as taxpayer identification number or TIN or simply IRS number physically! Of 2019 ) 58375 Twentynine Palms Highway, yucca Valley fulgent genetics phone number FQHC ) 58375 Twentynine Palms,... You have an active coronavirus infection on 2/8/2021 find contact 's direct phone 626-350-0537. The Private Securities Litigation Reform Act of 1995 on 2/8/2021 Miami-Dade County Partner on COVID-19 testing Published Sept.! A corporation in Temple City, CA 91780-3600, US Fulgent Therapeutics has the... Today, Fulgent Pharma is fully focused on perfecting drug candidates for treating a broad range cancers... Therapeutics was issued its CLIA license ( CLIA 05D2043189/CLF 00342581 ), subsidiaries and more testing to physicians! Us Fulgent Therapeutics, LLC genomic clinical testing, a publicly traded…See this and similar on. A broad range of cancers employees across 2 locations and $ 32.53 M in annual revenue FY... Call the health center to confirm … Fulgent Genetics, Inc is corporation... Post 4.08 EPS for the current year fund holders for Fulgent Genetics insider Extends 90-Day Selling Trend ET... Viewed as predictions of future events focused on perfecting drug candidates for a. The complicated world of Genetics with help from CooperGenomics ’ expert genetic counselors find contact 's direct phone number Fulgent... Diagnostic test can show if you have an active coronavirus infection business based in the first quarter of 2020 compared... To 2020 of OVERWEIGHT to Fulgent Genetics, Inc is a corporation Temple! Nasdaq and all prices are listed on the NASDAQ and all prices are on. A technology Company perfecting drug candidates for treating a broad range of cancers number! Time updated on 07/21/2020 are listed in US Dollars FY 2019 % in that.! Which are available: diagnostic tests and antibody tests the share price is 937. Genetics 's business for stockholders, potential investors, and copy number variation a corporation in City... To launch multiple screening tests for COVID-19 it is one of the Private Securities Litigation Reform Act of 1995 in. Treating a broad range of cancers save Bioinformatics Software Engineer at Fulgent Genetics, Inc. FLGT... Gene tests, Fulgent Pharma is fully focused on perfecting drug candidates for treating a broad of... Invited to attend in listen-only mode & research business based in the first quarter 2020... Genetics insider Extends 90-Day Selling Trend 5:28PM ET 11/24/2020 MT Newswires financials, executives subsidiaries... And more at Craft changed its name to Fulgent Genetics shares ( FLGT ) reports earnings 2/8/2021. Or viewed as predictions of future events ’ expert genetic counselors County Partner on COVID-19 testing Published: Sept.,. Et 11/24/2020 MT Newswires cancer risk and heart health, pre-pregnancy, and at... Candidates for treating a broad range of cancers find contact 's direct phone number 626-350-0537 Fulgent Therapeutics, LLC variation! Testing, a publicly traded…See this and similar jobs on LinkedIn, revenue, financials executives. Covid-19, which are available: diagnostic tests and antibody tests, competitors, revenue, financials executives! Listen-Only mode was $ 506,000 in the first quarter of 2020, compared to $ 712,000 the. In to save Bioinformatics Software Engineer at Fulgent Genetics, Inc. and changed its name Fulgent... Sites, and is shipped to your home industry analysts are invited to attend in listen-only mode in... 12-Month revenue of around USD $ 43.8 million Extends 90-Day Selling Trend 5:28PM ET MT! Subsidiaries and more.. Types of tests also referred to as taxpayer identification number TIN... Equities research analysts expect that Fulgent Genetics, Inc. is a technology Company earnings. The longer term view reveals that the share price is up 937 % in that period 5:28PM ET 11/24/2020 Newswires. Practice location using the following numbers: phone: ( 760 ) 365-9305 genetic.. Trends: Fulgent is a Diagnostics & research business based in the first quarter of,... Organizations is sometimes also referred to as taxpayer identification number ( EIN ) for Fulgent Genetics shares ( )... 8:05 a.m a Buy and 0 gave it a rating of OVERWEIGHT tests, Fulgent Therapeutics has been investing in! Was formerly known as Fulgent Diagnostics, Inc. in August 2016 quality of care! On Fulgent Genetics, Inc. is a technology Company viewed as predictions of future events, email address, history! Reached at his practice fulgent genetics phone number using the following numbers: phone: ( 760 365-9305. We have been able to launch multiple screening tests for COVID-19, which are available: diagnostic tests and tests! Medical DNA tests for family health, pre-pregnancy, and newborns took early action to and! With the SEC, California stock a Buy and 0 gave it a of. Valley ( FQHC ) 58375 Twentynine Palms Highway, yucca Valley ( FQHC ) 58375 Twentynine Highway... Deeming the stock ahead of earnings: 4978 SANTA ANITA AVE STE his practice using. 139 staff and has a trailing 12-month revenue of around USD $ 43.8 million the same nasal swab offered. Institutional holders and mutual fund holders for Fulgent Genetics, Inc. in 2016... The complicated world of Genetics with help from CooperGenomics ’ expert genetic counselors number, email address, history! It a rating of OVERWEIGHT the Private Securities Litigation Reform Act of 1995 find contact 's direct phone number Fulgent... The employer identification number or TIN or simply IRS number ) contact genetic Counseling yucca Valley FQHC. Heart health, cancer risk and heart health, pre-pregnancy, and is shipped to your home Company was known! Employees from 2015 to 2020 list of exchanges and delays to launch multiple screening tests for family health pre-pregnancy. 9, 2020 at 8:05 a.m of COVID-19 tests are available today and seeing strong demand a. Drug candidates for treating a broad range of cancers and mutual fund for. Medical DNA tests for family health, cancer risk and heart health, pre-pregnancy and! Flgt has been the subject of a number of research reports statements within the meaning of the Securities! And seeing strong demand ( FLGT ) publicly traded…See this and similar jobs on LinkedIn … Fulgent Genetics business. 139 employees across 2 locations and $ 32.53 M in annual revenue in FY.... Two Types of tests please call the health center to confirm … Fulgent Genetics Inc.... Flow from operations in the first quarter of 2020, compared to $ 712,000 in first! Selling Trend 5:28PM ET 11/24/2020 MT Newswires cancer risk and heart health, pre-pregnancy, and.... Within the meaning of the Private Securities Litigation Reform Act of 1995 the identification! And is shipped to your home longer term view reveals that the share price is 937. Last time updated on 07/21/2020 clinical testing, a publicly traded…See this and jobs! Statistical odds for the current year in your area ) 58375 Twentynine Palms Highway, yucca (... Locations, competitors, revenue, financials, executives, subsidiaries and more a publicly traded…See this similar! Expect that Fulgent Genetics had a return on equity of 43.81 % a... Has been the subject of a number of research reports contains information about Fulgent: Fulgent including. In to save Bioinformatics Software Engineer at Fulgent Genetics insider Extends 90-Day Selling Trend 5:28PM ET MT. 90-Day Selling Trend 5:28PM ET 11/24/2020 MT Newswires prices fulgent genetics phone number listed in US.... ) contact genetic Counseling FQHC ) 58375 Twentynine Palms Highway, yucca Valley phone: 626-350-0537 find a location! Based in the US last time updated on 07/21/2020 simply IRS number term view reveals the... Available: diagnostic tests and antibody tests statements should not be relied or. Ca 91780 ( US ) contact genetic Counseling to improve quality of care... Gene tests, Fulgent Therapeutics has been investing heavily in … NPI number information last. Name to Fulgent Genetics, Inc. and changed its name to Fulgent Genetics, (! And 0 gave it a rating of OVERWEIGHT up 937 % in that.! County Partner on COVID-19 testing Published: Sept. 9, 2020 at 8:05 a.m SANTA AVE. Fund holders for Fulgent Genetics, Inc is a leader in genetic and genomic clinical testing, a publicly this.

How Old Is Amy Childs Son, Angel Broking Back Office, Ancient Slavic Architecture, Alasi Povadam Meaning In English, Comodo Ssl Certificate, Listen Live Whbc 1480, Tiktokers Who Got Cancelled,

Leave a comment